Fort Washington Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2M | Sell |
|
|||||
|
2025
Q1 | $50.5M | Sell |
|
|||||
|
2024
Q4 | $47M | Sell |
|
|||||
|
2024
Q3 | $51.1M | Sell |
|
|||||
|
2024
Q2 | $80.6M | Sell |
|
|||||
|
2024
Q1 | $102M | Buy |
|
|||||
|
2023
Q4 | $112M | Sell |
|
|||||
|
2023
Q3 | $116M | Buy |
|
|||||
|
2023
Q2 | $102M | Buy |
|
|||||
|
2023
Q1 | $111M | Sell |
|
|||||
|
2022
Q4 | $119M | Buy |
|
|||||
|
2022
Q3 | $97.1M | Sell |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $95.2M | Buy |
|
|||||
|
2021
Q4 | $101M | Buy |
|
|||||
|
2021
Q3 | $45.7M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $391K | Hold |
|
|||||
|
2018
Q3 | $445K | Hold |
|
|||||
|
2018
Q2 | $432K | Sell |
|
|||||
|
2018
Q1 | $388K | Sell |
|
|||||
|
2017
Q4 | $534K | Sell |
|
|||||
|
2017
Q3 | $572K | Sell |
|
|||||
|
2017
Q2 | $704K | Sell |
|
|||||
|
2017
Q1 | $847K | Hold |
|
|||||
|
2016
Q4 | $799K | Hold |
|
|||||
|
2016
Q3 | $893K | Buy |
|
|||||
|
2016
Q2 | $727K | Buy |
|
|||||
|
2016
Q1 | $753K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.08M | Sell |
|
|||||
|
2015
Q2 | $1.59M | Sell |
|
|||||
|
2015
Q1 | $1.47M | Sell |
|
|||||
|
2014
Q4 | $1.07M | Buy |
|
|||||
|
2014
Q3 | $814K | Buy |
|
|||||
|
2014
Q2 | $655K | Buy |
|
|||||
|
2014
Q1 | $562K | Sell |
|
|||||
|
2013
Q4 | $6.24M | Sell |
|
|||||
|
2013
Q3 | $6.91M | Sell |
|
|||||
|
2013
Q2 | $11.7M | Buy |
|